Oral Semaglutide – Safety Information

Understanding Compounded Medications
Oral semaglutide drops are a compounded medication available by prescription and formulated to support medical weight loss through appetite suppression and blood sugar regulation. This formulation is not FDA-approved and has not been reviewed for safety, effectiveness, or manufacturing quality. Compounding allows for flexibility in dosing and accessibility when commercial options are unavailable.

Warnings & Potential Risks
Semaglutide mimics the GLP-1 hormone to help regulate appetite and glucose levels. While effective, it may carry side effects, especially in individuals with underlying health conditions.

Common Side Effects:

• Nausea or vomiting

• Diarrhea or constipation

• Bloating or abdominal pain

• Headache or fatigue

• Loss of appetite or early satiety

Serious Risks Include:

• Pancreatitis (Symptoms: severe stomach pain, vomiting)

• Gallbladder issues

• Kidney injury due to dehydration

• Thyroid C-cell tumors (based on animal studies – human relevance unknown)

Do Not Use If You:

• Have a history of medullary thyroid cancer or MEN2 syndrome

• Are pregnant, trying to conceive, or breastfeeding

• Have severe gastrointestinal disorders

• Are allergic to semaglutide or related compounds

Monitoring Required:
Patients should be monitored for blood sugar changes, gastrointestinal tolerance, and hydration status. Always inform your provider of any new symptoms.